Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.
Aspirin and multiple sclerosis.
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
[Optic neuritis: diagnosis, treatment and clinical implications].
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Early development of anti-natalizumab antibodies in MS patients.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.
Pages
« first
‹ previous
…
184
185
186
187
188
189
190
191
192
…
next ›
last »